Tech Center 3700 • Art Units: 3771 3774 3775 3791
This examiner grants 49% of resolved cases
Samuel Chong Kim serves as a patent examiner in Tech Center 3700, working within Art Unit 3771. He has overseen 234 resolved cases, which result in an allowance rate of 48.7 percent. The median days to allowance for these cases is 1374. This 1374 day timeline reflects the duration of prosecution for successful applications in this art unit. The 234 resolved cases provide the data for these performance metrics in Tech Center 3700.
The interview lift for Samuel Chong Kim is 70.4 percent, indicating that applications involving an interview have a higher probability of success than the 48.7 percent baseline allowance rate. For practitioners, this 70.4 percent lift suggests that direct communication is an extremely effective strategy for resolving issues. Given the 1374 day median pendency, the 70.4 percent lift may be a valuable tool for advancing prosecution. The 48.7 percent allowance rate and the 234 resolved cases define his profile in Art Unit 3771.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18759226 | METHOD FOR ESTIMATING WALKING INDEX OF USER AND ELECTRONIC DEVICE AND WEARABLE DEVICE FOR PERFORMING SAME | Non-Final OA | Samsung Electronics Co., Ltd. |
| 18926862 | SENSORS WITH ADHESIVE REGIONS | Non-Final OA | COVIDIEN LP |
| 18563039 | MEDICAL DEVICE AND METHOD FOR DETERMINING AN ORIENTATION OF SAME | Final Rejection | BIOTRONIK SE & Co. KG |
| 18820165 | METHODS AND SYSTEMS FOR PERIPHERAL VISION TESTING USING PROGRESSIVELY NARROWING FIELDS OF VIEW IN VIRTUAL REALITY | Non-Final OA | Zenni Optical, Inc. |
| 18842257 | COMPUTERIZED DECISION SUPPORT TOOL AND MEDICAL DEVICE FOR RESPIRATORY CONDITION MONITORING AND CARE | Non-Final OA | Pfizer Inc. |
| 18490842 | NON-INVASIVE BLOOD GLUCOSE MONITORING DEVICE | Final Rejection | Taiwan-Asia Semiconductor Corporation |
| 17054385 | INTRAOSSEOUS ACCESS DEVICE AND METHOD TO ACCESS BONE MARROW | Non-Final OA | TELEFLEX LIFE SCIENCES LIMITED |
| 18036741 | METHOD AND MEASURING DEVICE FOR CONTINUOUSLY NON-INVASIVELY DETERMINING AT LEAST ONE CARDIOVASCULAR PARAMETER | Final Rejection | CNSYSTEMS MEDIZINTECHNIK AG |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy